S Kumar1, M J Hossain2, A Javed3, I J Kullo4, P B Balagopal5. 1. Division of Pediatric Endocrinology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA. 2. Biostatistics Core, Nemours Biomedical Research, Wilmington, DE, USA. 3. Division of Pediatric and Adolescent Gynecology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA. 4. Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA. 5. Nemours Children's Specialty Care, Division of Biomedical Research, Mayo Clinic College of Medicine, Jacksonville, FL, USA.
Abstract
PURPOSE: Spexin, a novel peptide, has potential implications in obesity, satiety and energy homeostasis. The current study examined the relationship of spexin with various biomarkers of cardiovascular disease and endothelial function in adolescents with obesity. METHODS: Nineteen adolescents with obesity (age, 15.8 ± 1.7 years) were studied. Spexin, leptin and various cardiovascular disease biomarkers were measured. Endothelial function was assessed by high-resolution Doppler ultrasonography of the right brachial artery. RESULTS: Spexin concentration (median [interquartile range] 0.38 ng/mL [0.29-0.59 ng/mL]) was inversely correlated (r = -0.50, P = 0.03) with leptin. When participants were clustered into two groups ('high spexin and low leptin' vs. 'low spexin and high leptin'), the odds of having 'low spexin and high leptin' in participants with higher hs-CRP (≥ 3 mg/L) were 12.25 times (95 per cent CI -1 to139, P = 0.026) higher than those of participants with lower hs-CRP (<3 mg/L). Spexin levels, however, were not associated with measures of endothelial function. CONCLUSIONS: The inverse association between spexin and leptin and the presence of higher concentrations of hs-CRP in adolescents with obesity in the setting of 'low spexin and high leptin' suggest a potential role for spexin in the regulation of satiety and certain cardiovascular risk factors in children with obesity.
PURPOSE:Spexin, a novel peptide, has potential implications in obesity, satiety and energy homeostasis. The current study examined the relationship of spexin with various biomarkers of cardiovascular disease and endothelial function in adolescents with obesity. METHODS: Nineteen adolescents with obesity (age, 15.8 ± 1.7 years) were studied. Spexin, leptin and various cardiovascular disease biomarkers were measured. Endothelial function was assessed by high-resolution Doppler ultrasonography of the right brachial artery. RESULTS:Spexin concentration (median [interquartile range] 0.38 ng/mL [0.29-0.59 ng/mL]) was inversely correlated (r = -0.50, P = 0.03) with leptin. When participants were clustered into two groups ('high spexin and low leptin' vs. 'low spexin and high leptin'), the odds of having 'low spexin and high leptin' in participants with higher hs-CRP (≥ 3 mg/L) were 12.25 times (95 per cent CI -1 to139, P = 0.026) higher than those of participants with lower hs-CRP (<3 mg/L). Spexin levels, however, were not associated with measures of endothelial function. CONCLUSIONS: The inverse association between spexin and leptin and the presence of higher concentrations of hs-CRP in adolescents with obesity in the setting of 'low spexin and high leptin' suggest a potential role for spexin in the regulation of satiety and certain cardiovascular risk factors in children with obesity.
Authors: Andrea Porzionato; Marcin Rucinski; Veronica Macchi; Carla Stecco; Ludwik K Malendowicz; Raffaele De Caro Journal: J Histochem Cytochem Date: 2010-06-07 Impact factor: 2.479
Authors: Cheng-Yuan Lin; Ling Zhao; Tao Huang; Lin Lu; Mahjabin Khan; Jie Liu; Linda L D Zhong; Zong-Wei Cai; Bao-Min Fan; Anderson O L Wong; Zhao-Xiang Bian Journal: Front Physiol Date: 2018-04-10 Impact factor: 4.566
Authors: Nasser M Al-Daghri; Hazim A Al-Hazmi; Abdulrahman Al-Ajlan; Mohammad S Masoud; Abeer Al-Amro; Amani Al-Ghamdi; Abdullah M Alnaami; Omar S Al-Attas; Majed S Alokail Journal: Saudi J Biol Sci Date: 2018-01-20 Impact factor: 4.219
Authors: Matthew K H Wong; Yuan Chen; Mulan He; Chengyuan Lin; Zhaoxiang Bian; Anderson O L Wong Journal: Front Endocrinol (Lausanne) Date: 2021-07-02 Impact factor: 5.555
Authors: Malwina Prater; Russell S Hamilton; Hong Wa Yung; Andrew M Sharkey; Paul Robson; N Erlyani Abd Hamid; Eric Jauniaux; D Stephen Charnock-Jones; Graham J Burton; Tereza Cindrova-Davies Journal: Biol Open Date: 2021-06-08 Impact factor: 2.422